Sponsor
1 Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: A placebo-controlled, randomized study, Pain Research and Management, May 24, 2013
2 Willow bark extract STW 33-I in the long-term treatment of outpatients with rheumatic pain mainly osteoarthritis or back pain Phytomedicine, June 7, 2013
3 Dextrose prolotherapy for knee osteoarthritis: A randomized controlled trial Annals of Family Medicine, May 21, 2013
4 Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain Pain Physician, May 24, 2013
5 Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: Reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone Pain, May 20, 2013
6 Propofol for procedural sedation in the emergency department: a qualitative systematic review Annals of Pharmacotherapy, May 28, 2013 Review Article
7 Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids Addictive Behaviours, May 24, 2013
8 Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies Current Medical Research and Opinion, May 22, 2013
9 Time since diagnosis, treatment pathways and current pain status: a retrospective assessment in a back pain population Journal of Medical Economics , May 20, 2013
10 Postoperative opioid requirements following roux-en-y gastric bypass in patients receiving continuous bupivacaine through a pump system: a retrospective review Hospital Pharmacy, June 7, 2013 Review Article
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor